To further evaluate the potential role of a FAP+CAFs-mediated IL-31 overexpression in gastric cancer resistance to anti-PD-1 immunotherapy, a tumor model was established by subcutaneously implanting 615 mice with mouse gastric cancer MFC cells. The gene discussed is IL31; the disease is gastric cancer.